The questions that remain unanswered include the actual prevalence of sexual side effects (we do not know if it affects 5 percent or 30 percent of women), whether certain doses are more likely to cause sexual dysfunction than others, whether compounded semaglutide formulations produce different sexual side effect profiles than brand-name versions, whether specific pharmacy sources or compounding pharmacies produce formulations with different tolerability profiles, and whether pre-treatment screening can identify women at higher risk for sexual dysfunction on GLP-1 agonists
Recalls & Warnings July 13, 2023 1st phorm Level-1 Protein Supplements Recalled Due to Staph Risk On June 21, 2023, International Food Companies DBA International Food Products recalled two protein supplements due to potential contamination with Staphylococcus aureus
You might find that you don't hit that 3:00 PM wall as hard as you used to
Researchers continue to investigate how BPC-157 influences cellular migration, extracellular matrix remodeling, and communication between cells involved in connective tissue physiology
Regardless of mechanism, clinical observations support a nausea-reducing effect in a subset of users
Fatty acids consumption: The role metabolic aspects involved in obesity and its associated disorders
